Distinct immune response in two MERS-CoV-infected patients: Can we go from bench to bedside?

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Faure, Emmanuel ^a   Poissy, Julien ^b   Goffard, Anne ^b   Fournier, Clement ^b   Kipnis, Eric ^a   Titecat, Marie ^b   Bortolotti, Perinne ^a   Martinez, Laura ^a   Dubucquoi, Sylvain ^b   Dessein, Rodrigue ^a   Gosset, Philippe ^c,d   Mathieu, Daniel ^b   Guery, Benoit ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c INSERM U1019   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CYTOKINE; DOUBLE STRANDED RNA; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; VIRUS RNA;

ADAPTIVE IMMUNITY; ADULT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; CASE REPORT; CONTROLLED STUDY; CORONAVIRUS INFECTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTENSIVE CARE UNIT; LUNG ALVEOLUS CELL; LUNG LAVAGE; MALE; MEDICAL DECISION MAKING; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION; MORTALITY; POLYMERASE CHAIN REACTION; QUANTITATIVE STUDY; RNA EXTRACTION; TH1 CELL; TREATMENT PLANNING; VIRAL CLEARANCE; WORLD HEALTH ORGANIZATION;

ADAPTIVE IMMUNITY; CHEMOKINE CXCL10; CORONAVIRUS; CORONAVIRUS INFECTIONS; FATAL OUTCOME; HUMANS; IMMUNITY, INNATE; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-17; MALE; MIDDLE AGED; MIDDLE EAST; MODELS, IMMUNOLOGICAL; RESPIRATORY TRACT INFECTIONS; TRANSLATIONAL MEDICAL RESEARCH; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 84895823870     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088716     Document Type: Article

References (23)

1. Frieman M, Heise M, Baric R (2008) SARS coronavirus and innate immunity. Virus Res 133: 101-112. doi:10.1016/j.virusres.2007.03.015. (Pubitemid 351374752)
2. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367: 1814-1820. doi:10.1056/NEJMoa1211721.
3. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, et al. (2013) Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13: 752-761. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 23891402&retmode=ref&cmd=prlinks.
4. Katze MG, He Y, Gale M (2002) Viruses and interferon: a fight for supremacy. Nature Reviews Immunology 2: 675-687. Available: http://www.nature. com/doifinder/10.1038/nri888.
5. Takeuchi O, Akira S (2008) MDA5/RIG-I and virus recognition. Current opinion in immunology 20: 17-22. Available: http://linkinghub.elsevier.com/ retrieve/pii/S0952791508000046.
6. Blander JM, Sander LE (2012) Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nature Reviews Immunology 12: 215-225. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=22362354&retmode=ref&cmd=prlinks.
7. Perlman S, Netland J (2009) Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 7: 439-450. doi:10.1038/ nrmicro2147.
8. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737. Available: http://www.nature.com/doifinder/10.1038/ni1087.
9. Welsh RM, Waggoner SN (2013) NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections. Virology 435: 37-45. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 23217614&retmode=ref&cmd=prlinks.
10. Taniguchi T, Takaoka A (2001) A weak signal for strong responses: interferon-alpha/beta revisited. Nature Reviews Molecular Cell Biology 2: 378-386. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&id=11331912&retmode=ref&cmd=prlinks.
11. de Wilde AH, Raj VS, Oudshoorn D, Bestebroer TM, van Nieuwkoop S, et al. (2013) MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment. J Gen Virol 94: 1749-1760. doi:10.1099/vir.0.052910-0.
12. Guery B, Poissy J, Mansouf El L, Séjourné C, Ettahar N, et al. (2013) Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 381: 2265-2272. doi:10.1016/S0140-6736(13)60982-4.
13. See H, Wark P (2008) Innate immune response to viral infection of the lungs. Paediatric respiratory reviews 9: 243-250. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 19026365&retmode=ref&cmd=prlinks.
14. Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, et al. (2007) Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. Journal of Virology 81: 8692-8706. Available: http://eutils.ncbi.nlm. nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17537853&retmode= ref&cmd=prlinks.
15. Zhu M (2004) SARS Immunity and Vaccination. Cell Mol Immunol 1: 193-198. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom= pubmed&id=16219167&retmode=ref&cmd=prlinks.
16. Reghunathan R, Jayapal M, Hsu L-Y, Chng H-H, Tai D, et al. (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC immunology 6: 2. Available: http://eutils.ncbi.nlm. nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=15655079&retmode= ref&cmd=prlinks.
17. Josset L, Menachery VD, Gralinski LE, Agnihothram S, Sova P, et al. (2013) Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus. MBio 4: e00165-13-e00165-13. doi:10.1128/mBio.00165-13.
18. Wang Q, Zhou J, Zhang B, Tian Z, Tang J, et al. (2013) Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis. PLoS Pathog 9: e1003410. Available: http://eutils.ncbi. nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=23825942&retmode= ref&cmd=prlinks.
19. Kumar P, Chen K, Kolls JK (2013) Th17 cell based vaccines in mucosal immunity. Current opinion in immunology 25: 373-380. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 23669353&retmode=ref&cmd=prlinks.
20. Sabat R (2010) IL-10 family of cytokines. Cytokine and Growth Factor Reviews 21: 315-324. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/ elink.fcgi?dbfrom=pubmed&id=21112807&retmode=ref&cmd=prlinks.
21. Ysebrant de Lendonck L, Tonon S, Nguyen M, Vandevenne P, Welsby I, et al. (2013) Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes. Proc Natl Acad Sci USA. Available: http://eutils.ncbi.nlm.nih. gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=23918362&retmode= ref&cmd=prlinks.
22. Moore TC, Al-Salleeh FM, Brown DM, Petro TM (2011) IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages. Virology 418: 40-48. Available: http://eutils.ncbi.nlm.nih.gov/ entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21810534&retmode=ref&cmd= prlinks.
23. Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA (2013) Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis: 1-7. doi:10.1016/j.ijid.2013.07.002.